Cosmos Pharmaceutical Corp
TSE:3349
Cosmos Pharmaceutical Corp
TSE:3349
Price:
14 700 JPY
0.93%
Market Closed
Updated:
May 6, 2024
Cosmos Pharmaceutical Corp
Net Income (Common)
|
Cosmos Pharmaceutical Corp
Net Income (Common) Peer Comparison
Comparables:
9989
3391
3141
S
7649
3088
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Net Income (Common)
¥24.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
Sundrug Co Ltd
TSE:9989
|
Net Income (Common)
¥28.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Net Income (Common)
¥27.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Net Income (Common)
¥26.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Net Income (Common)
¥22B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Net Income (Common)
¥50.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
16%
|
CAGR 10-Years
15%
|
See Also
What is Cosmos Pharmaceutical Corp's Net Income (Common)?
Net Income (Common)
24.1B
JPY
24.1B
JPY
Based on the financial report for Nov 30, 2023, Cosmos Pharmaceutical Corp's Net Income (Common) amounts to 24.1B JPY.
What is Cosmos Pharmaceutical Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
9%
9%
Over the last year, the Net Income (Common) growth was 4%. The average annual Net Income (Common) growth rates for Cosmos Pharmaceutical Corp have been -2% over the past three years , 5% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
